Rapid Micro Biosystems, Inc. (RPID): Price and Financial Metrics


Rapid Micro Biosystems, Inc. (RPID): $1.62

-0.43 (-20.98%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

RPID POWR Grades

  • Sentiment is the dimension where RPID ranks best; there it ranks ahead of 90.08% of US stocks.
  • The strongest trend for RPID is in Growth, which has been heading up over the past 131 days.
  • RPID ranks lowest in Quality; there it ranks in the 2nd percentile.

RPID Stock Summary

  • RPID's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.53 -- higher than only 4.94% of US-listed equities with positive expected earnings growth.
  • RPID's went public 1.38 years ago, making it older than merely 3.61% of listed US stocks we're tracking.
  • As for revenue growth, note that RPID's revenue has grown -22.66% over the past 12 months; that beats the revenue growth of just 7.97% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to RAPID MICRO BIOSYSTEMS INC are POLA, FARO, PLAB, ICAD, and OSUR.
  • To check out RAPID MICRO BIOSYSTEMS INC's SEC filings, go to the company's page on browse-edgar?action=getcompany&CIK=0001380106.

RPID Valuation Summary

  • RPID's price/sales ratio is 5.3; this is 165% higher than that of the median Healthcare stock.
  • Over the past 17 months, RPID's EV/EBIT ratio has gone up 20.9.

Below are key valuation metrics over time for RPID.

Stock Date P/S P/B P/E EV/EBIT
RPID 2022-11-25 5.3 0.5 -1.6 -1.3
RPID 2022-11-23 5.2 0.5 -1.6 -1.3
RPID 2022-11-22 5.2 0.5 -1.6 -1.3
RPID 2022-11-21 5.2 0.5 -1.6 -1.3
RPID 2022-11-18 5.2 0.5 -1.6 -1.3
RPID 2022-11-17 5.4 0.5 -1.7 -1.3

RPID Price Target

For more insight on analysts targets of RPID, see our RPID price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $28.00 Average Broker Recommendation 1.5 (Moderate Buy)

RPID Stock Price Chart Interactive Chart >

Price chart for RPID

RPID Price/Volume Stats

Current price $1.62 52-week high $12.84
Prev. close $2.05 52-week low $1.60
Day low $1.60 Volume 1,564,000
Day high $2.09 Avg. volume 172,906
50-day MA $2.89 Dividend yield N/A
200-day MA $4.37 Market Cap 68.03M

Rapid Micro Biosystems, Inc. (RPID) Company Bio


Rapid Micro Biosystems, Inc. provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. It offers Growth Direct system that includes an automated imaging instrument that analyzes user-prepared proprietary consumables. The company also provides on-site installation, instrument, validation services, regulatory compliance assistance, system certification training and training re-freshers, and business case preparation and return-on-investment analysis services; and technical support services in the Americas and Europe. It solutions are used in environmental monitoring, water testing, and bioburden testing applications. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is based in Lowell, Massachusetts with an additional office in Freising/Weihenstephan, Germany.


RPID Latest News Stream


Event/Time News Detail
Loading, please wait...

RPID Latest Social Stream


Loading social stream, please wait...

View Full RPID Social Stream

Latest RPID News From Around the Web

Below are the latest news stories about RAPID MICRO BIOSYSTEMS INC that investors may wish to consider to help them evaluate RPID as an investment opportunity.

Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Tops Revenue Estimates

Rapid Micro Biosystems, Inc. (RPID) delivered earnings and revenue surprises of -2.70% and 20.43%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | November 10, 2022

Rapid Micro Biosystems Reports Third Quarter 2022 Financial Results

Reports third quarter 2022 commercial revenue of $4.7 million Delivered year-over-year recurring revenue growth of 34% Reaffirms full year 2022 commercial revenue guidance of at least $17.0 million LOWELL, Mass., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today an

Yahoo | November 10, 2022

Rapid Micro Biosystems to Announce Third Quarter 2022 Financial Results on November 10, 2022

LOWELL, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release third quarter 2022 financial results on Thursday, November 10th, prior to the market open.

GlobeNewswire | November 2, 2022

Rapid Micro Biosystems Announces RMBNucleus™ Mold Alarm for the Growth Direct® System

LOWELL, Mass., Oct. 10, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its newest product, RMBNucleus™ Mold Alarm, which is designed to rapidly detect environmental molds in the pharmaceutical manufacturing process. RMBNucleus™ Mold Alarm is expected to be available on the Growth Direct® System before the end of 2022.

GlobeNewswire | October 10, 2022

Rapid Micro to introduce RMBNucleus software for mold detection in pharma manufacturing

Rapid Micro Biosystems (RPID) said it introduced a new software, RMBNucleus Mold Alarm to rapidly detect environmental molds in the pharmaceutical manufacturing process.RMBNucleus…

Seeking Alpha | October 10, 2022

Read More 'RPID' Stories Here

RPID Price Returns

1-mo -45.08%
3-mo -53.58%
6-mo -63.84%
1-year -86.80%
3-year N/A
5-year N/A
YTD -84.77%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7264 seconds.